Best selling drugs of 2024
1-Keytruda, Merck, $29.482 billion
2-Ozempic, Novo Nordisk, $16.923
3-Biktarvy, Gilead Sciences, $13.423
4-Eliquis, Pfizer/BMS, $13.333
5-Dupixent, Sanofi/Regeneron, $13.72
6-Skyrizi, AbbVie, $11.718
7-Darzalex, Johnson & Johnson, $11.670
8-Stelara, Johnson & Johnson, $10.361
9-Opdivo, BMS/Ono Pharma, $9.304
10-Humira, AbbVie, $8.993
